Skip to content
Morgan, G. J., Child, J. A., Gregory, W. M., Szubert, A. J., Et al., National Cancer Research Institute Haematological Oncology Clinical Studies, Group Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial. Lancet Oncology 2011; 8: 743-52
Treatment of Metastatic Carcinoma and Myeloma of the Femur
-
Efficacy of Bone Modifying Agents
-
BMAs for Various Diagnosis